공시 • Jan 30
Genomma Lab Internacional, S.A.B. de C.V. to Report Q4, 2025 Results on Feb 25, 2026 Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q4, 2025 results After-Market on Feb 25, 2026 공시 • Dec 09
Genomma Lab Internacional Announces Fourteenth Dividend Payment, Payable on December 23, 2025 Genomma Lab Internacional, S.A.B. de C.V. informs that the Company presented a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.200000 Mexican pesos per share on its common stock representing a total amount of $200,000,000.00 M.N. (two hundred million pesos 00/100 National Currency), payable to shareholders of record of the applicable circulating shares at the close of business on December 23, 2025. This amount per share is based on the total LABB shares currently outstanding. 공시 • Oct 09
Genomma Lab Internacional, S.A.B. de C.V. to Report Q3, 2025 Results on Oct 22, 2025 Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q3, 2025 results After-Market on Oct 22, 2025 공시 • Jun 30
Genomma Lab Internacional, S.A.B. de C.V. to Report Q2, 2025 Results on Jul 23, 2025 Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q2, 2025 results After-Market on Jul 23, 2025 공시 • Jun 24
Genomma Lab Internacional, S.A.B. De C.V. Announces Twelfth Quarterly Dividend Payment, Payable on July 1, 2025 Genomma Lab Internacional, S.A.B. de C.V. informs that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.200000 Mexican pesos per share on its common stock representing a total amount of $200,000,000.00 M.N. (two hundred million pesos 00/100 National Currency), payable to shareholders of record of the applicable circulating shares at the close of business on July 1st, 2025. This amount per share is based on the total LABB shares currently outstanding. Subject to the terms and conditions established by the AGSM, the Company has the intention to make dividend payments on a Quarterly basis. 공시 • Apr 08
Genomma Lab Internacional, S.A.B. de C.V., Annual General Meeting, Apr 24, 2025 Genomma Lab Internacional, S.A.B. de C.V., Annual General Meeting, Apr 24, 2025. Location: antonio dovali jaime no 70, tower c 2nd floor, santa fe neighborhood, cp 01210, mexico Mexico 공시 • Apr 01
Genomma Lab Internacional, S.A.B. de C.V. to Report Q1, 2025 Results on Apr 30, 2025 Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q1, 2025 results After-Market on Apr 30, 2025 공시 • Mar 07
Genomma Lab Internacional Announces Eleventh Cash Dividend Payment Genomma Lab Internacional, S.A.B. de C.V. informed that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.200000 Mexican pesos per share on its common stock representing a total amount of $200,000,000.00 M.N. (two hundred million pesos 00/100 National Currency), payable to shareholders of record of the applicable circulating shares at the close of business on March 14, 2025. This amount per share is based on the total LABB shares currently outstanding. Genomma's Board of Directors, exercising the powers delegated at the Annual General Shareholders Meeting held on April 30, 2024 ("AGSM"), have therefore deemed it appropriate to make this announced dividend payment. Subject to the terms and conditions established by the AGSM, the Company has the intention to make dividend payments on a Quarterly basis. 공시 • Feb 11
Genomma Lab Internacional, S.A.B. de C.V. to Report Q4, 2024 Results on Feb 26, 2025 Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q4, 2024 results at 3:00 PM, Central Standard Time on Feb 26, 2025 공시 • Oct 05
Genomma Lab Internacional, S.A.B. de C.V. to Report Q3, 2024 Results on Oct 23, 2024 Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q3, 2024 results After-Market on Oct 23, 2024 공시 • Oct 03
Genomma Lab Pharma Manufacturing Facility Receives Pending GMP Certification for the Mexican Market from the Mexican Ministry of Health's Federal Committee Genomma Lab Internacional, S.A.B. de C.V. announced that it has received Good Manufacturing Practices ("GMP") certification from the Mexican Ministry of Health's Federal Committee for Protection from Sanitary Risks for its oral liquid, topical liquid and tablet coating manufacturing production at Genomma Lab's Medicinas y Medicamentos Nacionales, S.A. de C.V. manufacturing facility in the State of Mexico. 공시 • Jul 04
Genomma Lab Internacional, S.A.B. de C.V. to Report Q2, 2024 Results on Jul 24, 2024 Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q2, 2024 results After-Market on Jul 24, 2024 공시 • Jun 16
Genomma Lab Internacional, S.A.B. De C.V. Declares Cash Dividend Genomma Lab Internacional, S.A.B. de C.V. informs that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.200000 Mexican pesos per share on its common stock representing a total amount of $200,000,000.00 M.N., payable to shareholders of record of the applicable circulating shares at the close of business on June 21, 2024. This amount per share is based on the total LABB shares currently outstanding. Genomma's Board of Directors, exercising the powers delegated at the Annual General Shareholders Meeting held on April 30, 2024, have therefore deemed it appropriate to make this announced dividend payment. 공시 • Apr 05
Genomma Lab Internacional, S.A.B. de C.V. to Report Q1, 2024 Results on Apr 24, 2024 Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q1, 2024 results After-Market on Apr 24, 2024 공시 • Mar 14
Genomma Lab Internacional, S.A.B. De C.V. Declares Cash Dividend Genomma Lab Internacional, S.A.B. de C.V. informed that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of MXN 0.196080 per share on its common stock representing a total amount of MXN 200,001,600.00 payable to shareholders of record of the applicable circulating shares at the close of business on March 25, 2024. This amount per share is based on the total LABB shares currently outstanding. Genomma's Board of Directors, exercising the powers delegated at the Annual General Shareholders Meeting held on April 28, 2023 (AGSM), have therefore deemed it appropriate to make this seventh announced dividend payment. 공시 • Jan 24
Genomma Lab Internacional, S.A.B. de C.V. to Report Q4, 2023 Results on Feb 21, 2024 Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q4, 2023 results After-Market on Feb 21, 2024 공시 • Dec 14
Genomma Lab Internacional, S.A.B. De C.V. Announces Sixth Dividend Payment Genomma Lab Internacional, S.A.B. de C.V. (Genomma Lab) informed that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of MXN 0.196080 per share on its common stock representing a total amount of MXN 200,001,600.00, payable to shareholders of record of the applicable circulating shares at the close of business on December 27, 2023. 공시 • Oct 05
Genomma Lab Internacional, S.A.B. de C.V. to Report Q3, 2023 Results on Oct 25, 2023 Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q3, 2023 results After-Market on Oct 25, 2023 공시 • Jul 06
Genomma Lab Internacional, S.A.B. de C.V. to Report Q2, 2023 Results on Jul 26, 2023 Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q2, 2023 results After-Market on Jul 26, 2023 공시 • Jan 31
Genomma Lab Internacional, S.A.B. de C.V. to Report Q4, 2022 Results on Feb 22, 2023 Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q4, 2022 results After-Market on Feb 22, 2023 
